Clinical Trials Update: Aug. 31, 2009
Heart Disease Rheumatoid Arthritis Metastatic Colorectal Cancer
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
To qualify for this study of an investigational medication, you must be 18 or older and have had a heart attack or have had heart surgery.
The research site is in Chicago, Ill.
This study is for people with rheumatoid arthritis. Participants must be aged 18 to 70, and on a stable dose of methotrexate (15-25 mg.) for at least four weeks.
The research site is in Phoenix, Ariz.
Metastatic Colorectal Cancer
People with colorectal cancer that has metastasized (spread) may qualify for this study of an investigational regimen consisting of a human monoclonal antibody combined with chemotherapy.
The research site is in Paducah, Ky.
Copyright 2009ClinicalConnection.com. All rights reserved.